Phase I study of CKD-581, a pan-histone deacetylase inhibitor, in patients with lymphoma or multiple myeloma refractory to standard therapy.
| Image |  |
|---|---|
| Description | scientific article published on 9 March 2018 |
| Author/s |
author: Kyun-Seop Bae Cheolwon Suh Hyeon Seok Eom |
| Publication date | March 9, 2018 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |